Post by The Clatterbridge Cancer Centre NHS Foundation Trust

A research team working with The Clatterbridge Cancer Centre has been awarded more than £475,000 from Blood Cancer UK to continue and expand UNCOVER, one of the largest blood cancer data research programmes in the world. The funding will support UNCOVER for a further three years, helping researchers deepen understanding of how blood cancers are diagnosed, treated and how patients’ outcomes vary across England. The award includes £205,194 confirmed funding, with a further £270,006 dependent on annual milestone reviews. The UNCOVER study is sponsored by The Clatterbridge Cancer Centre, with analysis led by an expert team of health data scientists at the University of Liverpool. Prof Andy Pettitt, Consultant Haemato-Oncologist at Clatterbridge and Ronald Finn Professor of Experimental Medicine at the University of Liverpool, a Chief Investigator in the UNCOVER team, said: “This funding is a huge vote of confidence in UNCOVER and in the power of using real world NHS data to improve outcomes for people with blood cancer. “By bringing together clinicians, researchers and patients, we can ask better questions, generate more meaningful evidence and ensure that research leads to real change in care.” Read more on our website 👉 https://orlo.uk/SRRh3